NASDAQ:ACRX
$0.700
(
-2.76%
)
Friday, 24th Mar 2023
AcelRx Pharmaceuticals Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $0.569 | $1.51 | Friday, 24th Mar 2023 ACRX stock ended at $0.700. This is 2.76% less than the trading day before Thursday, 23rd Mar 2023. During the day the stock fluctuated 7.16% from a day low at $0.670 to a day high of $0.718. |
| 90 days | $0.569 | $2.78 | |
| 52 weeks | $0.160 | $4.14 |
Historical AcelRx Pharmaceuticals prices
| Date | Open | High | Low | Close | Volume |
| 2023-03-24 | $0.718 | $0.718 | $0.670 | $0.700 | 111 585 |
| 2023-03-23 | $0.730 | $0.745 | $0.670 | $0.720 | 201 772 |
| 2023-03-22 | $0.720 | $0.88 | $0.675 | $0.724 | 786 738 |
| 2023-03-21 | $0.600 | $0.700 | $0.591 | $0.685 | 236 911 |
| 2023-03-20 | $0.656 | $0.670 | $0.569 | $0.580 | 406 451 |
| 2023-03-17 | $0.710 | $0.730 | $0.648 | $0.660 | 219 152 |
| 2023-03-16 | $0.688 | $0.720 | $0.649 | $0.700 | 392 598 |
| 2023-03-15 | $0.84 | $0.84 | $0.611 | $0.710 | 1 107 439 |
| 2023-03-14 | $1.25 | $1.25 | $0.86 | $0.87 | 2 033 934 |
| 2023-03-13 | $1.17 | $1.18 | $1.06 | $1.10 | 176 757 |
| 2023-03-10 | $1.16 | $1.20 | $1.10 | $1.18 | 139 902 |
| 2023-03-09 | $1.17 | $1.20 | $1.11 | $1.15 | 110 427 |
| 2023-03-08 | $1.23 | $1.25 | $1.15 | $1.17 | 113 862 |
| 2023-03-07 | $1.29 | $1.32 | $1.15 | $1.21 | 126 319 |
| 2023-03-06 | $1.31 | $1.33 | $1.24 | $1.30 | 105 003 |
| 2023-03-03 | $1.29 | $1.33 | $1.27 | $1.31 | 67 089 |
| 2023-03-02 | $1.33 | $1.37 | $1.26 | $1.30 | 113 894 |
| 2023-03-01 | $1.43 | $1.43 | $1.30 | $1.32 | 133 114 |
| 2023-02-28 | $1.41 | $1.43 | $1.37 | $1.42 | 60 247 |
| 2023-02-27 | $1.39 | $1.45 | $1.34 | $1.36 | 59 370 |
| 2023-02-24 | $1.45 | $1.45 | $1.36 | $1.39 | 103 429 |
| 2023-02-23 | $1.44 | $1.47 | $1.35 | $1.44 | 150 751 |
| 2023-02-22 | $1.48 | $1.51 | $1.42 | $1.45 | 97 202 |
| 2023-02-21 | $1.55 | $1.58 | $1.43 | $1.48 | 183 371 |
| 2023-02-17 | $1.54 | $1.67 | $1.45 | $1.55 | 138 463 |
| 2023-02-16 | $1.55 | $1.59 | $1.50 | $1.55 | 106 631 |
| 2023-02-15 | $1.60 | $1.62 | $1.54 | $1.59 | 87 788 |
| 2023-02-14 | $1.66 | $1.74 | $1.52 | $1.61 | 248 267 |
| 2023-02-13 | $1.78 | $1.78 | $1.65 | $1.68 | 138 621 |
| 2023-02-10 | $1.82 | $1.86 | $1.70 | $1.76 | 194 354 |
| 2023-02-09 | $2.03 | $2.03 | $1.80 | $1.84 | 163 934 |
| 2023-02-08 | $2.08 | $2.08 | $1.85 | $1.94 | 160 484 |
| 2023-02-07 | $2.02 | $2.07 | $1.86 | $2.03 | 315 535 |
| 2023-02-06 | $2.12 | $2.12 | $1.96 | $2.02 | 177 695 |
| 2023-02-03 | $2.21 | $2.24 | $2.04 | $2.08 | 108 507 |
| 2023-02-02 | $2.16 | $2.30 | $2.05 | $2.20 | 171 027 |
| 2023-02-01 | $2.01 | $2.17 | $2.00 | $2.12 | 135 258 |
| 2023-01-31 | $1.97 | $2.10 | $1.95 | $2.00 | 190 302 |
| 2023-01-30 | $2.07 | $2.07 | $1.91 | $1.96 | 149 261 |
| 2023-01-27 | $2.10 | $2.14 | $1.95 | $1.99 | 211 164 |
| 2023-01-26 | $2.09 | $2.15 | $1.99 | $1.99 | 234 430 |
| 2023-01-25 | $2.17 | $2.17 | $2.04 | $2.10 | 91 867 |
| 2023-01-24 | $2.20 | $2.25 | $2.01 | $2.14 | 369 543 |
| 2023-01-23 | $2.22 | $2.31 | $2.10 | $2.18 | 166 010 |
| 2023-01-20 | $2.30 | $2.52 | $2.18 | $2.24 | 164 257 |
| 2023-01-19 | $2.35 | $2.47 | $2.24 | $2.30 | 68 700 |
| 2023-01-18 | $2.54 | $2.75 | $2.30 | $2.39 | 162 241 |
| 2023-01-17 | $2.61 | $2.67 | $2.53 | $2.58 | 76 379 |
| 2023-01-13 | $2.46 | $2.78 | $2.46 | $2.59 | 203 408 |
| 2023-01-12 | $2.29 | $2.61 | $2.24 | $2.50 | 330 800 |
About AcelRx Pharmaceuticals
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed and patient-controlled analgesia system that allows hospital patients with moderate-to-severe acute pai... ACRX Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
